This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.
COVID-19 Resource Center

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Log In

    Show
    Forgot your password?
    Log In
    Or create a new account (it's free)

    Forgot Password?

    Enter your email address and we'll send you a link to reset your password.

    Get New Password

    Sign In Required

    To save favorites, you must log in.

    Creating an account is free, easy, and takes about 60 seconds.

    Already have an MDCalc account?

    Login to link your favorites and recently used calcs

    Show
    Forgot your password?
    Log In
    Or continue to Nuance

    Attention COACH STUDY participants:

    The principal investigators of the study request that you use the official version of the modified score here.

    Management of Small Renal Masses (beta)

    Based on guidelines from the American Society of Clinical Oncology.

    Strength
    Strong recommendation
    Moderate recommendation
    Weak recommendation
    Evidence
    High quality evidence
    Intermediate quality evidence
    Low quality evidence
    Insufficient evidence

    Management

    Renal Tumor Biopsy
    1. On the basis of tumor-specific findings and competing risks of mortality, all patients with a small renal mass should be considered for renal tumor biopsy when the results may alter management.
    Active Surveillance
    1. Active surveillance should be an initial management option for patients who have significant comorbidities and limited life expectancy. Qualifying statement: absolute indication: high risk for anesthesia and intervention or life expectancy <5 years; relative indication: significant risk of end-stage renal disease if treated, small renal mass (<1 cm), or life expectancy <10 years.
    Partial Nephrectomy
    1. Partial nephrectomy for small renal masses is the standard treatment that should be offered to all patients for whom an intervention is indicated and who possess a tumor that is amenable to this approach.
    Percutaneous Thermal Ablation
    1. Percutaneous thermal ablation should be considered an option for patients who possess tumors such that complete ablation will be achieved. A biopsy should be obtained before or at the time of ablation.
    Radical Nephrectomy
    1. Radical nephrectomy for small renal masses should be reserved only for patients who possess a tumor of significant complexity that is not amenable to partial nephrectomy (PN) or where PN may result in unacceptable morbidity even when performed at centers with expertise. Referral to a surgeon and a center with experience in PN should be considered.
    Referral
    1. Referral to a nephrologist should be considered if chronic kidney disease (estimated glomerular filtration rate <45 mL/min/1.73m2) or progressive CKD develops after treatment, especially if associated with proteinuria.
    What do the icons mean?  
    Research PaperFinelli A, Ismaila N, Bro B, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(6):668-680.